IBD News Today

February 22, 2021February 23, 2021

Yuflyma, Biosimilar to Humira, Approved in EU for Chronic Inflammatory Diseases

IBD News Today

The European Commission (EC) has granted marketing authorization to Celltrion Healthcare‘s Yuflyma (CT-P17), a biosimilar to Humira (adalimumab). The marketing authorization includes all indications for which AbbVie’s Humira is approved, ... Read more

February 8, 2021February 9, 2021

Phage Therapy BX002 Shows Promise in First-in-human Trial

IBD News Today

BX002, an oral phage therapy BiomX is developing for inflammatory bowel disease (IBD), showed a good safety profile, as well as the ability to effectively deliver its active agent to ... Read more

February 1, 2021February 2, 2021

Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals

IBD News Today

Bacterial and fungal profiles found in fecal samples from people with inflammatory bowel disease (IBD) were able to predict the patients’ responses to the anti-inflammatory therapy infliximab, a study revealed. ... Read more

January 25, 2021January 26, 2021

Canada Approves At-home Entyvio Injection for Crohn’s

COVID-19 News, IBD News Today

Health Canada has approved a self-injectable subcutaneous (under-the-skin) form of Entyvio (vedolizumab) as an at-home maintenance therapy for adults with Crohn’s disease (CD). The approval follows an earlier decision to ... Read more

January 18, 2021January 19, 2021

Risankizumab for 12 Weeks Leads to Remission in Crohn’s Trials

IBD News Today

Treatment with risankizumab for 12 weeks (three months) induced both clinical and endoscopic remission in people with Crohn’s disease, a type of inflammatory bowel disease (IBD), new Phase 3 clinical ... Read more

January 11, 2021January 12, 2021

Clinical Benefits of ABX464 for Ulcerative Colitis Revealed in Review Study

COVID-19 News, IBD News Today

Abivax has published a review study summarizing the mechanisms, as well as the previously undisclosed clinical benefits of ABX464, its treatment candidate for people with inflammatory diseases, including ulcerative colitis ... Read more

January 4, 2021January 5, 2021

EU Reviewing Zeposia as Ulcerative Colitis Treatment for Adults

IBD News Today

The anti-inflammatory medication Zeposia (ozanimod) is under review in the European Union as a treatment for adults with moderately to severely active ulcerative colitis. The European Medicines Agency has validated ... Read more

December 21, 2020December 22, 2020

Rinvoq Found Safe, Effective for Ulcerative Colitis in Ongoing Phase 3 Trial

IBD News Today

Rinvoq (upadacitinib), AbbVie‘s investigational anti-inflammatory medicine, was found to be safe and effective in treating adults with moderate-to-severe ulcerative colitis (UC). The medication met all major endpoints in an ongoing ... Read more

December 21, 2020December 21, 2020

Abivax Completes Enrollment in ABX464 Trial for Ulcerative Colitis

COVID-19 News, IBD News Today

Abivax has completed patient enrollment, ahead of schedule and despite the COVID 19 pandemic, in its Phase 2b trial evaluating ABX464 as a treatment candidate for people with moderate-to-severe ulcerative ... Read more

December 7, 2020December 8, 2020

Takeda Partners With Universities on Research Into GI and Liver Disorders

IBD News Today

Takeda Pharmaceuticals has entered a five-year research collaboration with New York University and Columbia University to discover and develop new therapies for people with gastrointestinal and liver disorders. Gut inflammation, ... Read more

November 30, 2020December 1, 2020

Strain of Mouth Bacteria Linked to Severe Ulcerative Colitis, Study Reports

IBD News Today

A newly discovered strain of oral, or mouth bacteria was found to be associated with severe ulcerative colitis (UC) — a form of inflammatory bowel disease (IBD), a study reported.  ... Read more

November 9, 2020November 10, 2020

IBD Charitable Foundation Announces 2020 Sherman Prize Winners

COVID-19 News, IBD News Today

Two college professors — one from the University of Pennsylvania and the other from University of Chicago Medicine  — have been named the winners of the 2020 Sherman Prizes, which ... Read more

November 2, 2020November 2, 2020

Rare Microscopic Colitis in IBD Associated With More Active Inflammation, Study Reports

IBD News Today

Lymphocytic colitis (LC) and collagenous colitis (CC) occur rarely in people with inflammatory bowel disease (IBD) but are linked with more active inflammation, a study reports. The findings highlight the need ... Read more

October 26, 2020October 27, 2020

Healthy Gut Microbes Maintain Social Distance From Immune System, Study Finds

IBD News Today

Gut microbes found in feces avoid triggering immune reactions that could lead to conditions like inflammatory bowel disease (IBD) by creating a mucus barrier that separates them from immune cells, ... Read more

October 19, 2020October 20, 2020

Zeposia Effective in Keeping Ulcerative Colitis in Remission, Phase 3 Study Shows

IBD News Today

Zeposia (ozanimod), an investigational anti-inflammatory medicine, significantly increased clinical remission and mucosal healing in patients with ulcerative colitis (UC), a form of inflammatory bowel disease (IBD), Bristol Myers Squibb announced ... Read more